OMNICARE, INC. for OMNICARE INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Drug Enforcement Administration rule on disposal of controlled substances in long term care facilities; Reclassification of hydrocodone-containing prescription drugs from Schedule III to Schedule II drugs; Controlled substances policy; Biosimilars policy; Hazardous drug handling policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH TERRY | — |
Medicare/Medicaid MMM
Medicare Part D reimbursement; Medicare Part D audit policy; Medicare anti-fraud, waste and abuse policy; Medicaid FFS drug reimbursement; Medicare innovative health care and delivery models; Post-acute care payment policy reform; Medicare Part D network access issues; Safe-harbor and anti-kickback policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH TERRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.